Abbott Laboratories Non-GAAP EPS of $1.34 in-line, revenue of $11B misses by $30M
by
Contributor since / Followers
Contributor since / Followers
8 hours ago
- Abbott Laboratories press release (NYSE:ABT): Q4 Non-GAAP EPS of $1.34 in-line.
- Revenue of $11B (+7.2% Y/Y) misses by $30M.
- As expected, Diagnostics sales growth in the fourth quarter was negatively impacted by year-over-year declines in COVID-19 testing-related sales. Worldwide COVID-19 testing sales